Deliver to Argentina
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Trustpilot
Por Vikram D.
Hace 2 semanas
Por Neha S.
Pooja R.
Hace 1 semana
Khalid Z.